Reports

Industry Research Reports

Cell Immortalization - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Cell Immortalization - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-04-30

Pages: 130 Pages

Report ld: 6699255

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Cell Immortalization Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

5.9%

marketSize

Market Size,2032

USD 5,461

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 3,863 million
Market Forecast in 2032(Value)
US$ 5,461 million
CAGR
5.9%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Cell Immortalization was estimated to be worth US$ 3642 million in 2025 and is projected to reach US$ 5461 million, growing at a CAGR of 5.9% from 2026 to 2032.

Cell immortalization refers to the biological process of enabling primary cells to exceed their inherent proliferative limits and gain unlimited division capacity through physical, chemical, or biological means. Normal somatic cells have a limited number of passages in vitro, while immortalization extends cell life and establishes stable cell lines by activating telomerase (e.g., hTERT gene transfection), inactivating tumor suppressor proteins (p53/Rb, such as HPV E6/E7 or SV40 large T antigen), or viral transformation (EBV). Immortalized cells can maintain their original differentiation characteristics and genotype for a long period and are widely used in fields such as tumor research, drug screening, vaccine production, and gene therapy. Representative immortalization technologies include telomerase overexpression, proto-oncogene induction, and spontaneous immortalization. This technology is one of the core tools for modern biomedical basic research and product development.

The global cell immortalization market and research are characterized by a pattern of technological leadership from Europe and the United States, and accelerated application and translation in the Asia-Pacific region. North America, as a leading birthplace, continues to innovate in CRISPR, iPSC reprogramming, and telomerase regulation technologies. Companies such as ATCC and Thermo Fisher provide standard immortalization kits and cell banks, widely used in target discovery and gene therapy. Europe has a deep foundation in tumor biology and mechanism research. ECACC and DSMZ have extremely high requirements for the traceability and ethical standards of immortalized cell lines, promoting the international circulation of high-quality cell resources. The Asia-Pacific region (China, Japan, and South Korea) is experiencing rapid growth in the development of novel immortalization vectors (lentiviruses, transposons) and the construction of industrialized cell lines, especially driven by CRO/CDMO and biosimilars, with strong demand for industrial-grade suspension-acclimated immortalized cell lines (such as HEK293 and CHO). Future trends include: conditional immortalization systems based on CRISPRa/i, non-transgenic transient immortalization technologies, and alternative methods that reduce the use of primary animals in accordance with the 3R principle. Obstacles: Immortification may alter the original cell phenotype; long-term passage leads to karyotype instability, and regulatory concerns about tumorigenicity increase the difficulty of review. Updates: FDA guidelines encourage the use of fully characterized immortalized cell lines to replace animal experiments; China's CDE has released guidelines for stable cell lines used in gene therapy products, and the industry is actively promoting animal-free immortalized reagents.

This report provides a comprehensive view of the global market for Cell Immortalization, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Cell Immortalization market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Cell Immortalization.

MARKET SEGMENTATION

By Company

  • Lonza
  • Thermo Fisher Scientific
  • JSR
  • Sartorius
  • Merck
  • AcceGen
  • Creative Biolabs
  • InSCREENex GmbH
  • BioIVT
  • Krishgen Biosystems
  • Applied Biological Materials
  • REPROCELL Inc
  • FUJIFILM Wako Pure Chemical Corporation
  • Abace Biotechnology
  • CELLCOOK
  • Procell
  • Takara Bio
  • Corning
  • Evercyte

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Stem Cell Therapy
  • Cell Transplantation
  • Drug Transport
  • Others

Segment by Application

  • Pharmaceutical and Biopharmaceutical Company
  • Research Laboratory
  • Hospital
  • Other

Segment by Category

  • Human Cells
  • Mouse Cells
  • Non-mammal Cells
  • Others

Segment by Division

  • >30h
  • 24-30h
  • 18-24h
  • <18h

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

marn_i1

Chapter 2: Provides a detailed analysis of the Cell Immortalization companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

marn_i1

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 5: Presents Cell Immortalization revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

marn_i1

Chapter 6: Presents Cell Immortalization revenue at the country level. It provides segmented data by Type and by Application for each country/region.

marn_i1

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

marn_i1

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Cell Immortalization Product Introduction

1.2 Global Cell Immortalization Market Size Forecast (2021–2032)

1.3 Cell Immortalization Market Trends & Drivers

1.3.1 Cell Immortalization Industry Trends

1.3.2 Cell Immortalization Market Drivers & Opportunities

1.3.3 Cell Immortalization Market Challenges

1.3.4 Cell Immortalization Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Cell Immortalization Players Revenue Ranking (2025)

2.2 Global Cell Immortalization Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Cell Immortalization Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Cell Immortalization

2.6 Cell Immortalization Market Competitive Analysis

2.6.1 Cell Immortalization Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Cell Immortalization Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cell Immortalization revenue, 2025

2.7 Mergers & Acquisitions and Expansion

muLu

3 Segmentation Cell Immortalization Market Classification

3.1 Introduction by Type

3.1.1 Stem Cell Therapy

3.1.2 Cell Transplantation

3.1.3 Drug Transport

3.1.4 Others

3.1.5 Global Cell Immortalization Sales Value by Type

3.1.5.1 Global Cell Immortalization Sales Value by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Cell Immortalization Sales Value, by Type (2021–2032)

3.1.5.3 Global Cell Immortalization Sales Value, by Type (%), 2021–2032

3.2 Introduction by Cell Types

3.2.1 Human Cells

3.2.2 Mouse Cells

3.2.3 Non-mammal Cells

3.2.4 Others

3.2.5 Global Cell Immortalization Sales Value by Cell Types

3.2.5.1 Global Cell Immortalization Sales Value by Cell Types (2021 vs 2025 vs 2032)

3.2.5.2 Global Cell Immortalization Sales Value, by Cell Types (2021–2032)

3.2.5.3 Global Cell Immortalization Sales Value, by Cell Types (%), 2021–2032

3.3 Introduction by Doubling Time

3.3.1 >30h

3.3.2 24-30h

3.3.3 18-24h

3.3.4 <18h

3.3.5 Global Cell Immortalization Sales Value by Doubling Time

3.3.5.1 Global Cell Immortalization Sales Value by Doubling Time (2021 vs 2025 vs 2032)

3.3.5.2 Global Cell Immortalization Sales Value, by Doubling Time (2021–2032)

3.3.5.3 Global Cell Immortalization Sales Value, by Doubling Time (%), 2021–2032

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceutical and Biopharmaceutical Company

4.1.2 Research Laboratory

4.1.3 Hospital

4.1.4 Other

4.2 Global Cell Immortalization Sales Value by Application

4.2.1 Global Cell Immortalization Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Cell Immortalization Sales Value by Application (2021–2032)

4.2.3 Global Cell Immortalization Sales Value by Application (%), 2021–2032

muLu

5 Segmentation by Region

5.1 Global Cell Immortalization Sales Value by Region

5.1.1 Global Cell Immortalization Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Cell Immortalization Sales Value by Region (2021–2026)

5.1.3 Global Cell Immortalization Sales Value by Region (2027–2032)

5.1.4 Global Cell Immortalization Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Cell Immortalization Sales Value, 2021–2032

5.2.2 North America Cell Immortalization Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Cell Immortalization Sales Value, 2021–2032

5.3.2 Europe Cell Immortalization Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Cell Immortalization Sales Value, 2021–2032

5.4.2 Asia Pacific Cell Immortalization Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Cell Immortalization Sales Value, 2021–2032

5.5.2 South America Cell Immortalization Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Cell Immortalization Sales Value, 2021–2032

5.6.2 Middle East & Africa Cell Immortalization Sales Value by Country (%), 2025 vs 2032

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Cell Immortalization Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Cell Immortalization Sales Value, 2021–2032

6.3 United States

6.3.1 United States Cell Immortalization Sales Value, 2021–2032

6.3.2 United States Cell Immortalization Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Cell Immortalization Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Cell Immortalization Sales Value, 2021–2032

6.4.2 Europe Cell Immortalization Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Cell Immortalization Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Cell Immortalization Sales Value, 2021–2032

6.5.2 China Cell Immortalization Sales Value by Type (%), 2025 vs 2032

6.5.3 China Cell Immortalization Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Cell Immortalization Sales Value, 2021–2032

6.6.2 Japan Cell Immortalization Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Cell Immortalization Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Cell Immortalization Sales Value, 2021–2032

6.7.2 South Korea Cell Immortalization Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Cell Immortalization Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Cell Immortalization Sales Value, 2021–2032

6.8.2 Southeast Asia Cell Immortalization Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Cell Immortalization Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Cell Immortalization Sales Value, 2021–2032

6.9.2 India Cell Immortalization Sales Value by Type (%), 2025 vs 2032

6.9.3 India Cell Immortalization Sales Value by Application, 2025 vs 2032

muLu

7 Company Profiles

7.1 Lonza

7.1.1 Lonza Profile

7.1.2 Lonza Main Business

7.1.3 Lonza Cell Immortalization Products, Services, and Solutions

7.1.4 Lonza Cell Immortalization Revenue (US$ Million), 2021–2026

7.1.5 Lonza Recent Developments

7.2 Thermo Fisher Scientific

7.2.1 Thermo Fisher Scientific Profile

7.2.2 Thermo Fisher Scientific Main Business

7.2.3 Thermo Fisher Scientific Cell Immortalization Products, Services, and Solutions

7.2.4 Thermo Fisher Scientific Cell Immortalization Revenue (US$ Million), 2021–2026

7.2.5 Thermo Fisher Scientific Recent Developments

7.3 JSR

7.3.1 JSR Profile

7.3.2 JSR Main Business

7.3.3 JSR Cell Immortalization Products, Services, and Solutions

7.3.4 JSR Cell Immortalization Revenue (US$ Million), 2021–2026

7.3.5 JSR Recent Developments

7.4 Sartorius

7.4.1 Sartorius Profile

7.4.2 Sartorius Main Business

7.4.3 Sartorius Cell Immortalization Products, Services, and Solutions

7.4.4 Sartorius Cell Immortalization Revenue (US$ Million), 2021–2026

7.4.5 Sartorius Recent Developments

7.5 Merck

7.5.1 Merck Profile

7.5.2 Merck Main Business

7.5.3 Merck Cell Immortalization Products, Services, and Solutions

7.5.4 Merck Cell Immortalization Revenue (US$ Million), 2021–2026

7.5.5 Merck Recent Developments

7.6 AcceGen

7.6.1 AcceGen Profile

7.6.2 AcceGen Main Business

7.6.3 AcceGen Cell Immortalization Products, Services, and Solutions

7.6.4 AcceGen Cell Immortalization Revenue (US$ Million), 2021–2026

7.6.5 AcceGen Recent Developments

7.7 Creative Biolabs

7.7.1 Creative Biolabs Profile

7.7.2 Creative Biolabs Main Business

7.7.3 Creative Biolabs Cell Immortalization Products, Services, and Solutions

7.7.4 Creative Biolabs Cell Immortalization Revenue (US$ Million), 2021–2026

7.7.5 Creative Biolabs Recent Developments

7.8 InSCREENex GmbH

7.8.1 InSCREENex GmbH Profile

7.8.2 InSCREENex GmbH Main Business

7.8.3 InSCREENex GmbH Cell Immortalization Products, Services, and Solutions

7.8.4 InSCREENex GmbH Cell Immortalization Revenue (US$ Million), 2021–2026

7.8.5 InSCREENex GmbH Recent Developments

7.9 BioIVT

7.9.1 BioIVT Profile

7.9.2 BioIVT Main Business

7.9.3 BioIVT Cell Immortalization Products, Services, and Solutions

7.9.4 BioIVT Cell Immortalization Revenue (US$ Million), 2021–2026

7.9.5 BioIVT Recent Developments

7.10 Krishgen Biosystems

7.10.1 Krishgen Biosystems Profile

7.10.2 Krishgen Biosystems Main Business

7.10.3 Krishgen Biosystems Cell Immortalization Products, Services, and Solutions

7.10.4 Krishgen Biosystems Cell Immortalization Revenue (US$ Million), 2021–2026

7.10.5 Krishgen Biosystems Recent Developments

7.11 Applied Biological Materials

7.11.1 Applied Biological Materials Profile

7.11.2 Applied Biological Materials Main Business

7.11.3 Applied Biological Materials Cell Immortalization Products, Services, and Solutions

7.11.4 Applied Biological Materials Cell Immortalization Revenue (US$ Million), 2021–2026

7.11.5 Applied Biological Materials Recent Developments

7.12 REPROCELL Inc

7.12.1 REPROCELL Inc Profile

7.12.2 REPROCELL Inc Main Business

7.12.3 REPROCELL Inc Cell Immortalization Products, Services, and Solutions

7.12.4 REPROCELL Inc Cell Immortalization Revenue (US$ Million), 2021–2026

7.12.5 REPROCELL Inc Recent Developments

7.13 FUJIFILM Wako Pure Chemical Corporation

7.13.1 FUJIFILM Wako Pure Chemical Corporation Profile

7.13.2 FUJIFILM Wako Pure Chemical Corporation Main Business

7.13.3 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Products, Services, and Solutions

7.13.4 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Revenue (US$ Million), 2021–2026

7.13.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments

7.14 Abace Biotechnology

7.14.1 Abace Biotechnology Profile

7.14.2 Abace Biotechnology Main Business

7.14.3 Abace Biotechnology Cell Immortalization Products, Services, and Solutions

7.14.4 Abace Biotechnology Cell Immortalization Revenue (US$ Million), 2021–2026

7.14.5 Abace Biotechnology Recent Developments

7.15 CELLCOOK

7.15.1 CELLCOOK Profile

7.15.2 CELLCOOK Main Business

7.15.3 CELLCOOK Cell Immortalization Products, Services, and Solutions

7.15.4 CELLCOOK Cell Immortalization Revenue (US$ Million), 2021–2026

7.15.5 CELLCOOK Recent Developments

7.16 Procell

7.16.1 Procell Profile

7.16.2 Procell Main Business

7.16.3 Procell Cell Immortalization Products, Services, and Solutions

7.16.4 Procell Cell Immortalization Revenue (US$ Million), 2021–2026

7.16.5 Procell Recent Developments

7.17 Takara Bio

7.17.1 Takara Bio Profile

7.17.2 Takara Bio Main Business

7.17.3 Takara Bio Cell Immortalization Products, Services, and Solutions

7.17.4 Takara Bio Cell Immortalization Revenue (US$ Million), 2021–2026

7.17.5 Takara Bio Recent Developments

7.18 Corning

7.18.1 Corning Profile

7.18.2 Corning Main Business

7.18.3 Corning Cell Immortalization Products, Services, and Solutions

7.18.4 Corning Cell Immortalization Revenue (US$ Million), 2021–2026

7.18.5 Corning Recent Developments

7.19 Evercyte

7.19.1 Evercyte Profile

7.19.2 Evercyte Main Business

7.19.3 Evercyte Cell Immortalization Products, Services, and Solutions

7.19.4 Evercyte Cell Immortalization Revenue (US$ Million), 2021–2026

7.19.5 Evercyte Recent Developments

muLu

8 Industry Chain Analysis

8.1 Cell Immortalization Value Chain

8.2 Cell Immortalization Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Cell Immortalization Sales Model

8.5.2 Sales Channels

8.5.3 Cell Immortalization Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Cell Immortalization Market Trends
Table 2. Cell Immortalization Market Drivers & Opportunities
Table 3. Cell Immortalization Market Challenges
Table 4. Cell Immortalization Market Restraints
Table 5. Global Cell Immortalization Revenue by Company (US$ Million), 2021–2026
Table 6. Global Cell Immortalization Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Cell Immortalization Product Type
Table 9. Key Companies General Availability (GA) Timeline for Cell Immortalization
Table 10. Global Cell Immortalization Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cell Immortalization revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Cell Immortalization Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Cell Immortalization Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Cell Immortalization Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Cell Immortalization Sales Market Share in Value by Type (2021–2026)
Table 17. Global Cell Immortalization Sales Market Share in Value by Type (2027–2032)
Table 18. Global Cell Immortalization Sales Value by Cell Types: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Cell Immortalization Sales Value by Cell Types (US$ Million), 2021–2026
Table 20. Global Cell Immortalization Sales Value by Cell Types (US$ Million), 2027–2032
Table 21. Global Cell Immortalization Sales Market Share in Value by Cell Types (2021–2026)
Table 22. Global Cell Immortalization Sales Market Share in Value by Cell Types (2027–2032)
Table 23. Global Cell Immortalization Sales Value by Doubling Time: 2021 vs 2025 vs 2032 (US$ Million)
Table 24. Global Cell Immortalization Sales Value by Doubling Time (US$ Million), 2021–2026
Table 25. Global Cell Immortalization Sales Value by Doubling Time (US$ Million), 2027–2032
Table 26. Global Cell Immortalization Sales Market Share in Value by Doubling Time (2021–2026)
Table 27. Global Cell Immortalization Sales Market Share in Value by Doubling Time (2027–2032)
Table 28. Global Cell Immortalization Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Cell Immortalization Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Cell Immortalization Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Cell Immortalization Sales Market Share in Value by Application (2021–2026)
Table 32. Global Cell Immortalization Sales Market Share in Value by Application (2027–2032)
Table 33. Global Cell Immortalization Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 34. Global Cell Immortalization Sales Value by Region (US$ Million), 2021–2026
Table 35. Global Cell Immortalization Sales Value by Region (US$ Million), 2027–2032
Table 36. Global Cell Immortalization Sales Value by Region (%), 2021–2026
Table 37. Global Cell Immortalization Sales Value by Region (%), 2027–2032
Table 38. Key Countries/Regions Cell Immortalization Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 39. Key Countries/Regions Cell Immortalization Sales Value, (US$ Million), 2021–2026
Table 40. Key Countries/Regions Cell Immortalization Sales Value, (US$ Million), 2027–2032
Table 41. Lonza Basic Information List
Table 42. Lonza Description and Business Overview
Table 43. Lonza Cell Immortalization Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Cell Immortalization Business of Lonza (2021–2026)
Table 45. Lonza Recent Developments
Table 46. Thermo Fisher Scientific Basic Information List
Table 47. Thermo Fisher Scientific Description and Business Overview
Table 48. Thermo Fisher Scientific Cell Immortalization Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Cell Immortalization Business of Thermo Fisher Scientific (2021–2026)
Table 50. Thermo Fisher Scientific Recent Developments
Table 51. JSR Basic Information List
Table 52. JSR Description and Business Overview
Table 53. JSR Cell Immortalization Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Cell Immortalization Business of JSR (2021–2026)
Table 55. JSR Recent Developments
Table 56. Sartorius Basic Information List
Table 57. Sartorius Description and Business Overview
Table 58. Sartorius Cell Immortalization Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Cell Immortalization Business of Sartorius (2021–2026)
Table 60. Sartorius Recent Developments
Table 61. Merck Basic Information List
Table 62. Merck Description and Business Overview
Table 63. Merck Cell Immortalization Products, Services, and Solutions
Table 64. Revenue (US$ Million) in Cell Immortalization Business of Merck (2021–2026)
Table 65. Merck Recent Developments
Table 66. AcceGen Basic Information List
Table 67. AcceGen Description and Business Overview
Table 68. AcceGen Cell Immortalization Products, Services, and Solutions
Table 69. Revenue (US$ Million) in Cell Immortalization Business of AcceGen (2021–2026)
Table 70. AcceGen Recent Developments
Table 71. Creative Biolabs Basic Information List
Table 72. Creative Biolabs Description and Business Overview
Table 73. Creative Biolabs Cell Immortalization Products, Services, and Solutions
Table 74. Revenue (US$ Million) in Cell Immortalization Business of Creative Biolabs (2021–2026)
Table 75. Creative Biolabs Recent Developments
Table 76. InSCREENex GmbH Basic Information List
Table 77. InSCREENex GmbH Description and Business Overview
Table 78. InSCREENex GmbH Cell Immortalization Products, Services, and Solutions
Table 79. Revenue (US$ Million) in Cell Immortalization Business of InSCREENex GmbH (2021–2026)
Table 80. InSCREENex GmbH Recent Developments
Table 81. BioIVT Basic Information List
Table 82. BioIVT Description and Business Overview
Table 83. BioIVT Cell Immortalization Products, Services, and Solutions
Table 84. Revenue (US$ Million) in Cell Immortalization Business of BioIVT (2021–2026)
Table 85. BioIVT Recent Developments
Table 86. Krishgen Biosystems Basic Information List
Table 87. Krishgen Biosystems Description and Business Overview
Table 88. Krishgen Biosystems Cell Immortalization Products, Services, and Solutions
Table 89. Revenue (US$ Million) in Cell Immortalization Business of Krishgen Biosystems (2021–2026)
Table 90. Krishgen Biosystems Recent Developments
Table 91. Applied Biological Materials Basic Information List
Table 92. Applied Biological Materials Description and Business Overview
Table 93. Applied Biological Materials Cell Immortalization Products, Services, and Solutions
Table 94. Revenue (US$ Million) in Cell Immortalization Business of Applied Biological Materials (2021–2026)
Table 95. Applied Biological Materials Recent Developments
Table 96. REPROCELL Inc Basic Information List
Table 97. REPROCELL Inc Description and Business Overview
Table 98. REPROCELL Inc Cell Immortalization Products, Services, and Solutions
Table 99. Revenue (US$ Million) in Cell Immortalization Business of REPROCELL Inc (2021–2026)
Table 100. REPROCELL Inc Recent Developments
Table 101. FUJIFILM Wako Pure Chemical Corporation Basic Information List
Table 102. FUJIFILM Wako Pure Chemical Corporation Description and Business Overview
Table 103. FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Products, Services, and Solutions
Table 104. Revenue (US$ Million) in Cell Immortalization Business of FUJIFILM Wako Pure Chemical Corporation (2021–2026)
Table 105. FUJIFILM Wako Pure Chemical Corporation Recent Developments
Table 106. Abace Biotechnology Basic Information List
Table 107. Abace Biotechnology Description and Business Overview
Table 108. Abace Biotechnology Cell Immortalization Products, Services, and Solutions
Table 109. Revenue (US$ Million) in Cell Immortalization Business of Abace Biotechnology (2021–2026)
Table 110. Abace Biotechnology Recent Developments
Table 111. CELLCOOK Basic Information List
Table 112. CELLCOOK Description and Business Overview
Table 113. CELLCOOK Cell Immortalization Products, Services, and Solutions
Table 114. Revenue (US$ Million) in Cell Immortalization Business of CELLCOOK (2021–2026)
Table 115. CELLCOOK Recent Developments
Table 116. Procell Basic Information List
Table 117. Procell Description and Business Overview
Table 118. Procell Cell Immortalization Products, Services, and Solutions
Table 119. Revenue (US$ Million) in Cell Immortalization Business of Procell (2021–2026)
Table 120. Procell Recent Developments
Table 121. Takara Bio Basic Information List
Table 122. Takara Bio Description and Business Overview
Table 123. Takara Bio Cell Immortalization Products, Services, and Solutions
Table 124. Revenue (US$ Million) in Cell Immortalization Business of Takara Bio (2021–2026)
Table 125. Takara Bio Recent Developments
Table 126. Corning Basic Information List
Table 127. Corning Description and Business Overview
Table 128. Corning Cell Immortalization Products, Services, and Solutions
Table 129. Revenue (US$ Million) in Cell Immortalization Business of Corning (2021–2026)
Table 130. Corning Recent Developments
Table 131. Evercyte Basic Information List
Table 132. Evercyte Description and Business Overview
Table 133. Evercyte Cell Immortalization Products, Services, and Solutions
Table 134. Revenue (US$ Million) in Cell Immortalization Business of Evercyte (2021–2026)
Table 135. Evercyte Recent Developments
Table 136. Revenue (US$ Million) in Cell Immortalization Business of Company 40 (2021–2026)
Table 137. Company 40 Recent Developments
Table 138. Key Raw Materials Lists
Table 139. Key Suppliers of Raw Materials Lists
Table 140. Cell Immortalization Downstream Customers
Table 141. Cell Immortalization Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Cell Immortalization Product Picture
Figure 2. Global Cell Immortalization Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 4. Cell Immortalization Report Years Considered
Figure 5. Global Cell Immortalization Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cell Immortalization Revenue in 2025
Figure 7. Cell Immortalization Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Stem Cell Therapy Picture
Figure 9. Cell Transplantation Picture
Figure 10. Drug Transport Picture
Figure 11. Others Picture
Figure 12. Global Cell Immortalization Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Cell Immortalization Sales Value Market Share by Type, 2025 & 2032
Figure 14. Human Cells Picture
Figure 15. Mouse Cells Picture
Figure 16. Non-mammal Cells Picture
Figure 17. Others Picture
Figure 18. Global Cell Immortalization Sales Value by Cell Types (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Cell Immortalization Sales Value Market Share by Cell Types, 2025 & 2032
Figure 20. >30h Picture
Figure 21. 24-30h Picture
Figure 22. 18-24h Picture
Figure 23. <18h Picture
Figure 24. Global Cell Immortalization Sales Value by Doubling Time (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Cell Immortalization Sales Value Market Share by Doubling Time, 2025 & 2032
Figure 26. Product Picture of Pharmaceutical and Biopharmaceutical Company
Figure 27. Product Picture of Research Laboratory
Figure 28. Product Picture of Hospital
Figure 29. Product Picture of Other
Figure 30. Global Cell Immortalization Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 31. Global Cell Immortalization Sales Value Market Share by Application, 2025 & 2032
Figure 32. North America Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 33. North America Cell Immortalization Sales Value by Country (%), 2025 vs 2032
Figure 34. Europe Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 35. Europe Cell Immortalization Sales Value by Country (%), 2025 vs 2032
Figure 36. Asia Pacific Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 37. Asia Pacific Cell Immortalization Sales Value by Subregion (%), 2025 vs 2032
Figure 38. South America Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 39. South America Cell Immortalization Sales Value by Country (%), 2025 vs 2032
Figure 40. Middle East & Africa Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 41. Middle East & Africa Cell Immortalization Sales Value by Country (%), 2025 vs 2032
Figure 42. Key Countries/Regions Cell Immortalization Sales Value (%), 2021–2032
Figure 43. United States Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 44. United States Cell Immortalization Sales Value by Type (%), 2025 vs 2032
Figure 45. United States Cell Immortalization Sales Value by Application (%), 2025 vs 2032
Figure 46. Europe Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 47. Europe Cell Immortalization Sales Value by Type (%), 2025 vs 2032
Figure 48. Europe Cell Immortalization Sales Value by Application (%), 2025 vs 2032
Figure 49. China Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 50. China Cell Immortalization Sales Value by Type (%), 2025 vs 2032
Figure 51. China Cell Immortalization Sales Value by Application (%), 2025 vs 2032
Figure 52. Japan Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 53. Japan Cell Immortalization Sales Value by Type (%), 2025 vs 2032
Figure 54. Japan Cell Immortalization Sales Value by Application (%), 2025 vs 2032
Figure 55. South Korea Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 56. South Korea Cell Immortalization Sales Value by Type (%), 2025 vs 2032
Figure 57. South Korea Cell Immortalization Sales Value by Application (%), 2025 vs 2032
Figure 58. Southeast Asia Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 59. Southeast Asia Cell Immortalization Sales Value by Type (%), 2025 vs 2032
Figure 60. Southeast Asia Cell Immortalization Sales Value by Application (%), 2025 vs 2032
Figure 61. India Cell Immortalization Sales Value (US$ Million), 2021–2032
Figure 62. India Cell Immortalization Sales Value by Type (%), 2025 vs 2032
Figure 63. India Cell Immortalization Sales Value by Application (%), 2025 vs 2032
Figure 64. Cell Immortalization Value Chain
Figure 65. Cell Immortalization Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Cell Immortalization market size from 2026 to 2032?zhanKai
The annual compound growth rate of the global Cell Immortalization market is 5.9% 2026 to 2032.
Which companies rank high in the global Cell Immortalization market?shouQi
What was the global market size of Cell Immortalization in 2026?shouQi
What was the global market size of Cell Immortalization in 2032?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Cell Immortalization - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-04-30

Pages: 130 Pages

Report ld: 6699255

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now